MOUNT ROYAL, N.J.--(BUSINESS WIRE)--The American Headache Society (AHS) will host its 2024 Annual Scientific Meeting on June 13-16. Attendees can participate in-person or virtually, gaining evidence-based information on diagnosing, managing, and treating headache disorders. Register for the meeting here.
"It is an exciting time in the field of headache medicine,” said Dr. Christina Szperka, Co-Chair of the AHS Scientific Planning Committee. Co-Chair Dr. Mark Burish added, “This meeting attracts the world's leading experts in headache medicine who serve as our faculty as we look to advance the society's mission." The meeting includes diverse speakers featuring pioneers and visionaries who have left an indelible mark on their respective fields. Among them is a trailblazer whose illustrious career spans over seventy years, shaping the landscape of headache medicine and leaving an enduring legacy of excellence.
The keynote session will be on Artificial Intelligence (AI) in research and its clinical applications to headache medicine. More than 300 abstracts will be presented in preclinical science, epidemiology, diagnosis, and treatment. New data will be unveiled that has the potential to have a significant impact on a broad range of patient populations, including:
- Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial
- Identifying and Predicting Headache Trajectories Amongst Those with Acute Post-Traumatic Headache
- Genetic Variation and its Role in Post Traumatic Headache
- Development of PACAP and PAC1 targeting therapies for the Treatment of Opioid-Induced Medication Overuse Headache
- Real-World Use of Gepants for Prevention in Pediatric Patients with Chronic Headache Disorders
- Beyond "Other": Exploring Representation of Minoritized Individuals in Headache Research
The meeting will also feature awards given to the top studies of the year including Dr. Chia-Chun Chiang of the Mayo Clinic, recipient of the Harold G. Wolff Lecture Award. Her paper “Advancing Towards Precision Migraine Treatment: Predicting Responses to Preventive Medications with Machine Learning Models Based on Patient and Migraine Features” will be presented as the best paper on headache, head or face pain, or the nature of pain itself.
The full program agenda is available online here. Media can obtain passes to gain access to all meeting content. Online access to presentations will be available following the live meeting.
AHS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. Attendees can earn up to 31.50 AMA PRA Category 1 Credits™ while learning the latest advancements in headache medicine.
For more information about the American Headache Society and its events, programs, and membership, visit americanheadachesociety.org. Live Meeting updates will be posted on all AHS outlets, @ahsheadache, and is easily searchable using #AHSAM.
About the American Headache Society (AHS)
Our mission is to improve the care and lives of people living with headache disorders. Educating physicians, health professionals and the public, and encouraging scientific research are the primary functions of our Society. For more information about the AHS, visit americanheadachesociety.org.
